INO

INO

USD

Inovio Pharmaceuticals Inc. Common Stock

$2.430+0.000 (0.000%)

Precio en Tiempo Real

Healthcare
Biotecnología
Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$2.430

Máximo

$2.575

Mínimo

$2.410

Volumen

1.91M

Fundamentos de la Empresa

Capitalización de Mercado

129.1M

Industria

Biotecnología

País

United States

Estadísticas de Negociación

Volumen Promedio

1.60M

Bolsa

NCM

Moneda

USD

Rango de 52 Semanas

Mínimo $1.3Actual $2.430Máximo $5.8

Noticias Relacionadas

PR Newswire

INOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in Adults

INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...

Ver más
INOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in Adults
PR Newswire

INOVIO Reports Inducement Grant Under Inducement Plan

INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...

Ver más
INOVIO Reports Inducement Grant Under Inducement Plan
PR Newswire

INOVIO to Report Third Quarter 2025 Financial Results on November 10, 2025

INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...

Ver más
INOVIO to Report Third Quarter 2025 Financial Results on November 10, 2025
PR Newswire

INOVIO to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference

INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...

Ver más
INOVIO to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference
PR Newswire

Clinical Proof-of-Concept Data for DNA-Encoded Monoclonal Antibodies (DMAbs) Published in Nature Medicine

INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...

Ver más
Clinical Proof-of-Concept Data for DNA-Encoded Monoclonal Antibodies (DMAbs) Published in Nature Medicine

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.